Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts
Table 4
Clinical outcomes at 1 year stratified by tertiles of SYNTAX score II.
Outcomes at one year
SxSIILow≤21.5
SxSIIMid 21.5–30.6
SxSIIHigh ≥30.6
value
All-cause mortality
2 (0.8)
3 (1.2)
23 (9.4)
<0.001
28 (3.8)
Cardiovascular death
1 (0.4)
3 (1.2)
17 (7.0)
<0.001
21 (2.8)
Noncardiovascular death
1 (0.4)
0 (0.0)
6 (2.4)
0.007
7 (0.9)
Cerebrovascular event
0 (0.0)
1 (0.4)
3 (1.2)
0.134
4 (0.5)
Myocardial infarction
1 (0.4)
9 (3.7)
10 (4.1)
0.011
20 (2.7)
Clinically driven revascularization
4 (1.6)
16 (6.5)
21 (8.6)
0.002
41 (5.6)
Target vessel revascularization
2 (1.7)
13(5.3)
13 (5.3)
0.011
28 (3.8)
Any revascularization
4 (1.6)
18(7.3)
21 (8.6)
0.002
43 (5.8)
Restenotic lesion revascularisation
3 (1.7%)
2 (1.2%)
9 (1.8%)
0.03
14 (1.9)
Any stent thrombosis
2 (1.1%)
0 (0%)
3 (1.9%)
0.59
5 (0.6)
Early thrombosis
1 (0.6%)
0 (0%)
2 (1.3%)
0.50
3 (0.4)
Late thrombosis
1 (0.6%)
0 (0%)
1 (0.6%)
0.77
2 (0.2)
MACE
5 (2.0)
20 (8.2)
35 (14.3)
<0.001
60 (7.4)
MACCE
6 (2.4)
21 (8.6)
43 (17.6)
<0.001
70(9.5)
MACE, major adverse cardiac events; MACCE, major adverse cardiac and cerebrovascular events.
